ANI Pharmaceuticals Inc (STU:BSFA)
€ 53 -0.5 (-0.93%) Market Cap: 1.13 Bil Enterprise Value: 1.19 Bil PE Ratio: 50.37 PB Ratio: 2.68 GF Score: 86/100

Q2 2019 ANI Pharmaceuticals Inc Earnings Call Transcript

Aug 07, 2019 / 02:30PM GMT
Release Date Price: €71.46 (-2.24%)
Operator

Good morning, everyone, and welcome to ANI's Second Quarter 2019 Earnings Call. (Operator Instructions)

Please note, this call may be recorded. It is now my pleasure to turn today's program over to Mr. Arthur Przybyl. Please go ahead.

Arthur S. Przybyl
ANI Pharmaceuticals, Inc. - President, CEO & Director

Good morning, everyone. Welcome to ANI's earnings conference call for the second quarter 2019. My name is Art Przybyl, I'm the CEO. And joining me today is Stephen Carey, our Chief Financial Officer.

Before we begin, I want to refer everyone to the forward-looking statements language in this morning's press release and ask each of you to review it carefully as important context for this conference call. Discussions will also include certain financial measures that were not prepared in accordance with generally accepted accounting principles. Reconciliation of both non-GAAP financial measures can be found in our earnings release dated today.

Today, ANI reported second quarter 2019 results. For the second quarter, we reported

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot